Compounded semaglutide is not the same as Ozempic or Wegovy, and it should not be described as a generic version of either
Eli Lilly, the pharmaceutical company developing retatrutide, has progressed the compound into Phase 3 clinical trials, which are evaluating its efficacy and safety in larger populations across multiple indications, including obesity and type 2 diabetes
It is in this context that semaglutide and tirzepatide were developed
Retatrutide targets three, adding the glucagon receptor
It's more about adjusting rather than eliminating
Surgery is a valid, proactive tool that can save lives. It can certainly be a good option to consider for an individual if they meet the criteria, says Johnson-Rabbett